Business

MedX Health Corp. and Medical Marketing Berlin Sign Letter of Intent (LOI) for the North American Marketing Rights to Cardiology Telemedicine Technology

MedX Health Corp. and Medical Marketing Berlin Sign Letter of Intent (LOI) for the North American...

articleMedx Health Corp.July 29, 20104/company/medx-health-corp/news/medx-health-corp-and-medical-marketing-berlin-sign-letter-of-intent-loi-for-the-north-american-marketing-rights-to-cardiology-telemedicine-technology
MedX Health Corp. and Medical Marketing Berlin Sign Letter of Intent (LOI) for the North American Marketing Rights to Cardiology Telemedicine Technology

About this update from Medx Health Corp.

[{"type":"text","content":"\n\n\n\n Jul. 29, 2010 (Canada NewsWire Group) -- \n \n \n H'andy sana 211 cell phone with integrated ECG capability\n\nMISSISSAUGA, ON, July 29 /CNW/ - MedX Health Corp., (TSXV.MDX) a global leader in drug free, non-invasive low level laser and light therapy for tissue repair and pain relief, announced today that they have signed a Letter of Intent (LOI) with Medical Marketing Berlin GmbH (MMB) for the exclusive North American marketing rights to the H'andy sana 211, a touch screen cell phone with an integrated ECG, a drug reminder and a "Health Suite" in which blood glucose, cholesterol and blood pressure, etc, can be managed.\nMedical Marketing Berlin had previously obtained the worldwide rights for this technology. The device allows cardiac patients to measure an ECG in a critical situation remotely, and to send it via SMS to a telemedicine centre, hospital, or private physician to receive an immediate evaluation.\n"We are pleased to have a signed Letter of Intent with MMB to bring this important product to North America. Cardiology experts agree that the remote monitoring capabilities by devices, such as the H'andy sana 211 will reduce the cost of care for the health care system, by allowing patients to reduce the number of unnecessary office visits and expensive tests, as well as by identifying problems earlier before a crisis exits, This agreement gives us a strategic entry into this important market," stated Steve Guillen, president and CEO of MedX Health Corp.\nA final agreement will be subject to TSX Exchange, Board, and shareholder approvals as well as any required third-party consents, satisfactory due diligence, and the signing of a definitive agreement.\n\nAbout H'andy sana 211\n\nA comparison study demonstrated that the 1-lead ECG via the H'andy sana produced identical results with the corresponding leads of a standard 12-lead ECG record. Both ECG records were tested in parallel under clinical conditions. Following the study, Dr. Hans Lehmkuhl, chief cardiologist at the German Heart Centre in Berlin, Germany stated that he was "impressed and satisfied with the quality of the ECG recordings using the H'andy sana phone."\nThe H'andy sana 211 has a 2.8 inch full touch screen and full-fledged mobile phone capabilities, including a multimedia suite, internet browser, calendar, built-in cam...

More updates from Medx Health Corp.